1Discussion on the mechanisms of couplet medicine of "Bupleuri Radix-Angelicae Sinensis Radix"for mammary gland hyperplasia based on network pharmacology and molecular dockingYUAN Mingyang, ZHOU Xuegang, HU Dandan, JIANG Lei, YANG Bo, PENG Haisheng71-782Separation and purification of casein anticoagulant peptide and determination of its anticoagulant activityLIU Lisha, MIAO Yanli, CHEN Shaohong, ZHANG Liu, LU Xiao79-823Study on acute and long-term toxicity of Ganlanqianggu TabletsZHOU Zexuan, ZHANG Ting, LIANG Guodong, LIU Weidong, XIAO Yunfeng83-87,1214Simultaneous determination of five components in Ganmaoshufeng Tablets by HPLCLI Qi, TIAN Jing88-915Study on the quality control of skin ingredients of donkey in donkey-hide gelatin pastryZHAO Yanxia, JIANG Shuyin, GONG Liping, SHI Feng, CHENG Chunlei, LUO Xuegang92-95,1066Research on the historical evolution of Alisma orientaleZHANG Liqiang, LI Yuanyuan, JU Chengguo96-997Optimization of processing technology of Psoraleae Fructus with wineCHEN Lidong, ZHANG Xueshun, LIU Xiaoqian100-1038Protection of subjects in phase Ⅰ clinical trials during normalized anti-epidemic periodCAI Baole, MA Pengcheng104-1069Research and recent progress of rectal drug delivery systemZHOU Chunhui, HAN Xiaolu, LI Meng, WANG Zengming, LI Chunmei, WANG Xiangtao, ZHENG Aiping107-11210Research progress of signal pathways related to the pathogenesis of uric acid nephropathyGAO Tianshu, XIAO Yuxiao, SU Xiaoyu, LI Jiaqi, CHEN Jiajia, HU Weifeng, JIA Yuhan, WANG Xing, CHEN Zhen113-11611Research progress on cardiovascular activities of berberine hydrochlorideLIN Qingwei, LI Peibo, WU Hao, PENG Wei, ZHONG Hualin, SU Weiwei, CHENG Chunlei, WANG Yonggang117-12112The overview of techniques of AD drug developments targeting tau proteinZHONG Suyue, TAN Qiulong, YAO Xuanbao, YANG Jiaying, XIAO Shifeng122-12613Clinical observation on the effect of Simiao Powder on coagulation index in the treatment of acute gouty arthritisJING Rongyue, XU Lei, XU Changsong, XU Meimei, GUO Liang, CHEN Yueyue127-13014Application of subject-achieving quality control circle in improving pharmaceutical care for patients with chronic hepatitis BGONG Yinhua, ZHANG Ping, HONG Xiao, CHEN Rong, XU Wenjie, ZHU Jianguo131-135,14015Characteristics and outcomes analysis of 1120 adverse drug reactions/eventsLIN Mao, LIU Minhui, CHEN Chongze, DAI Hengfen136-140